Metabolomics and its application to acute lung diseases

Frontiers in Immunology

Volumn 7, Issue FEB, 2016, Pages

  Stringer, Kathleen A ^a   McKay, Ryan T ^b   Karnovsky, Alla ^c   Quémerais, Bernadette ^b   Lacy, Paige ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Acute respiratory distress syndrome; Biomarkers; Environmental exposure; Mass spectroscopy; Metabolites; Nuclear magnetic resonance; Pneumonia; Precision medicine

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACETIC ACID; CHOLESTEROL; CHOLINE; CREATINE; DNA; GLUCOSE; GLYCINE; HEXANAL; HISTIDINE; HYDROXYLAMINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; ISOLEUCINE; LACTIC ACID; LEUCINE; LIPID; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; OLEAMIDE; ORNITHINE; RNA; SPHINGANINE; SPHINGOSINE; TOLL LIKE RECEPTOR 4; TOXIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; URIC ACID;

ADULT RESPIRATORY DISTRESS SYNDROME; CAPILLARY ELECTROPHORESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); HUMAN; LIQUID CHROMATOGRAPHY; LUNG DISEASE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHENOTYPE; PNEUMONIA; REVIEW; SEPSIS; SILYLATION; VENTILATOR INDUCED LUNG INJURY;

EID: 84962486115     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00044     Document Type: Review

References (164)

1. Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol (2012) 13(4):263-9. doi: 10.1038/nrm3314.
2. Stringer KA, Serkova NJ, Karnovsky A, Guire K, Paine R III, Standiford TJ. Metabolic consequences of sepsis-induced acute lung injury revealed by plasma (1)H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol (2011) 300(1):L4-11. doi:10.1152/ajplung.00231.2010.
3. Cacciatore S, Loda M. Innovation in metabolomics to improve personalized healthcare. Ann N Y Acad Sci (2015) 1346(1):57-62. doi:10.1111/nyas.12775.
4. Madsen R, Lundstedt T, Trygg J. Chemometrics in metabolomics-a review in human disease diagnosis. Anal Chim Acta (2010) 659(1-2):23-33. doi:10.1016/j.aca.2009.11.042.
5. Robertson DG, Watkins PB, Reily MD. Metabolomics in toxicology: preclinical and clinical applications. Toxicol Sci (2011) 120(Suppl 1):S146-70. doi:10.1093/toxsci/kfq358.
6. Wishart DS. Advances in metabolite identification. Bioanalysis (2011) 3(15):1769-82. doi:10.4155/bio.11.155.
7. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev (2011) 40(1):387-426. doi:10.1039/b906712b.
8. Wishart DS. Current progress in computational metabolomics. Brief Bioinform (2007) 8(5):279-93. doi:10.1093/bib/bbm030.
9. Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, et al. The human serum metabolome. PLoS One (2011) 6(2):e16957. doi:10.1371/journal.pone.0016957.
10. Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, et al. The human urine metabolome. PLoS One (2013) 8(9):e73076. doi:10.1371/journal.pone.0073076.
11. Wishart DS. Metabolomics: the principles and potential applications to transplantation. Am J Transplant (2005) 5(12):2814-20. doi:10.1111/j.1600-6143.2005.01119.x.
12. Wishart DS. Computational approaches to metabolomics. In: Matthiesen R, editor. Bioinformatics Methods in Clinical Research Methods in Molecular Biology. 593. New York: Humana Press (2010). p. 283-313.
13. Slupsky CM, Cheypesh A, Chao DV, Fu H, Rankin KN, Marrie TJ, et al. Streptococcus pneumoniae and Staphylococcus aureus pneumonia induce distinct metabolic responses. J Proteome Res (2009) 8(6):3029-36. doi:10.1021/pr900103y.
14. Freidlin B, Korn EL. Biomarker enrichment strategies: matching trial design to biomarker credentials. Nat Rev Clin Oncol (2014) 11(2):81-90. doi:10.1038/nrclinonc.2013.218.
15. Blaus A, Madabushi R, Pacanowski M, Rose M, Schuck RN, Stockbridge N, et al. Personalized cardiovascular medicine today: a food and drug administration/center for drug evaluation and research perspective. Circulation (2015) 132(15):1425-32. doi:10.1161/CIRCULATIONAHA.114.009761.
16. Xia J, Broadhurst DI, Wilson M, Wishart DS. Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics (2013) 9(2):280-99. doi:10.1007/s11306-012-0482-9.
17. Emwas AH, Luchinat C, Turano P, Tenori L, Roy R, Salek RM, et al. Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review. Metabolomics (2015) 11(4):872-94. doi:10.1007/s11306-014-0746-7.
18. Angus DC. Fusing randomized trials with big data: the key to self-learning health care systems? JAMA (2015) 314(8):767-8. doi:10.1001/jama.2015.7762.
19. Gebregiworgis T, Powers R. Application of NMR metabolomics to search for human disease biomarkers. Comb Chem High Throughput Screen (2012) 15(8):595-610. doi:10.2174/138620712802650522.
20. Park Y, Kim SB, Wang B, Blanco RA, Le NA, Wu S, et al. Individual variation in macronutrient regulation measured by proton magnetic resonance spectroscopy of human plasma. Am J Physiol Regul Integr Comp Physiol (2009) 297(1):R202-9. doi:10.1152/ajpregu.90757.2008.
21. Serkova NJ, Standiford TJ, Stringer KA. The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med (2011) 184(6):647-55. doi:10.1164/rccm.201103-0474CI.
22. Leikauf GD, Pope-Varsalona H, Concel VJ, Liu P, Bein K, Berndt A, et al. Integrative assessment of chlorine-induced acute lung injury in mice. Am J Respir Cell Mol Biol (2012) 47(2):234-44. doi:10.1165/rcmb.2012-0026OC.
23. Knottnerus JA, Muris JW. Assessment of the accuracy of diagnostic tests: the cross-sectional study. J Clin Epidemiol (2003) 56(11):1118-28. doi:10.1016/S0895-4356(03)00206-3.
24. Leon Z, Garcia-Canaveras JC, Donato MT, Lahoz A. Mammalian cell metabolomics: experimental design and sample preparation. Electrophoresis (2013) 34(19):2762-75. doi:10.1002/elps.201200605.
25. Broadhurst DI, Kell DB. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics (2006) 2(4):171-96. doi:10.1007/s11306-006-0037-z.
26. Stringer KA, Younger JG, McHugh C, Yeomans L, Finkel MA, Puskarich MA, et al. Whole blood reveals more metabolic detail of the human metabolome than serum as measured by 1H-NMR spectroscopy: implications for sepsis metabolomics. Shock (2015) 44(3):200-8. doi:10.1097/SHK.0000000000000406.
27. Abuja PM, Ehrhart F, Schoen U, Schmidt T, Stracke F, Dallmann G, et al. Alterations in human liver metabolome during prolonged cryostorage. J Proteome Res (2015) 14(7):2758-68. doi:10.1021/acs.jproteome.5b00025.
28. Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Turano P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR (2011) 49(3-4):231-43. doi:10.1007/s10858-011-9489-1.
29. Breier M, Wahl S, Prehn C, Fugmann M, Ferrari U, Weise M, et al. Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples. PLoS One (2014) 9(2):e89728. doi:10.1371/journal.pone.0089728.
30. Lorenz MA, Burant CF, Kennedy RT. Reducing time and increasing sensitivity in sample preparation for adherent mammalian cell metabolomics. Anal Chem (2011) 83(9):3406-14. doi:10.1021/ac103313x.
31. Rosenling T, Stoop MP, Smolinska A, Muilwijk B, Coulier L, Shi S, et al. The impact of delayed storage on the measured proteome and metabolome of human cerebrospinal fluid. Clin Chem (2011) 57(12):1703-11. doi:10.1373/clinchem.2011.167601.
32. Mahrous EA, Farag MA. Two dimensional NMR spectroscopic approaches for exploring plant metabolome: a review. J Adv Res (2015) 6(1):3-15. doi:10.1016/j.jare.2014.10.003.
33. Zhao J, Evans CR, Carmody LA, LiPuma JJ. Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosis. J Cyst Fibros (2015) 14(4):468-73. doi:10.1016/j.jcf.2015.02.004.
34. Tzoulaki I, Ebbels TM, Valdes A, Elliott P, Ioannidis JP. Design and analysis of metabolomics studies in epidemiologic research: a primer on-omic technologies. Am J Epidemiol (2014) 180(2):129-39. doi:10.1093/aje/kwu143.
35. Overmyer KA, Thonusin C, Qi NR, Burant CF, Evans CR. Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model. PLoS One (2015) 10(2):e0117232. doi:10.1371/journal.pone.0117232.
36. Lacy P, McKay RT, Finkel M, Karnovsky A, Woehler S, Lewis MJ, et al. Signal intensities derived from different NMR probes and parameters contribute to variations in quantification of metabolites. PLoS One (2014) 9(1):e85732. doi:10.1371/journal.pone.0085732.
37. Beckonert O, Coen M, Keun HC, Wang Y, Ebbels TM, Holmes E, et al. High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat Protoc (2010) 5(6):1019-32. doi:10.1038/nprot.2010.45.
38. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc (2007) 2(11):2692-703. doi:10.1038/nprot.2007.376.
39. Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc (2012) 7(5):872-81. doi:10.1038/nprot.2012.024.
40. Dunn WB, Wilson ID, Nicholls AW, Broadhurst D. The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis (2012) 4(18):2249-64. doi:10.4155/bio.12.204.
41. Alonso A, Marsal S, Julia A. Analytical methods in untargeted metabolomics: state of the art in 2015. Front Bioeng Biotechnol (2015) 3:23. doi:10.3389/fbioe.2015.00023.
42. Sas KM, Karnovsky A, Michailidis G, Pennathur S. Metabolomics and diabetes: analytical and computational approaches. Diabetes (2015) 64(3):718-32. doi:10.2337/db14-0509.
43. Bos LD, Sterk PJ, Schultz MJ. Measuring metabolomics in acute lung injury: choosing the correct compartment? Am J Respir Crit Care Med (2012) 185(7):789. doi:10.1164/ajrccm.185.7.789.
44. Du X, Zeisel SH. Spectral deconvolution for gas chromatography mass spectrometry-based metabolomics: current status and future perspectives. Comput Struct Biotechnol J (2013) 4:e201301013. doi:10.5936/csbj.201301013.
45. Gika HG, Theodoridis GA, Plumb RS, Wilson ID. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics. J Pharm Biomed Anal (2014) 87:12-25. doi:10.1016/j.jpba.2013.06.032.
46. Milne SB, Mathews TP, Myers DS, Ivanova PT, Brown HA. Sum of the parts: mass spectrometry-based metabolomics. Biochemistry (2013) 52(22):3829-40. doi:10.1021/bi400060e.
47. Serkova NJ, Brown MS. Quantitative analysis in magnetic resonance spectroscopy: from metabolic profiling to in vivo biomarkers. Bioanalysis (2012) 4(3):321-41. doi:10.4155/bio.11.320.
48. Naz S, Moreira dos Santos DC, Garcia A, Barbas C. Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues. Bioanalysis (2014) 6(12):1657-77. doi:10.4155/bio.14.119.
49. Maciejewski MW, Mobli M, Schuyler AD, Stern AS, Hoch JC. Data sampling in multidimensional NMR: fundamentals and strategies. Top Curr Chem (2012) 316:49-77. doi:10.1007/128_2011_185.
50. Buscher JM, Czernik D, Ewald JC, Sauer U, Zamboni N. Cross-platform comparison of methods for quantitative metabolomics of primary metabolism. Anal Chem (2009) 81(6):2135-43. doi:10.1021/ac8022857.
51. Evans CR, Karnovsky A, Kovach MA, Standiford TJ, Burant CF, Stringer KA. Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health. J Proteome Res (2014) 13(2):640-9. doi:10.1021/pr4007624.
52. Zhao YY, Wu SP, Liu S, Zhang Y, Lin RC. Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications. Chem Biol Interact (2014) 220:181-92. doi:10.1016/j.cbi.2014.06.029.
53. Naz S, Garcia A, Rusak M, Barbas C. Method development and validation for rat serum fingerprinting with CE-MS: application to ventilator-induced-lung-injury study. Anal Bioanal Chem (2013) 405(14):4849-58. doi:10.1007/s00216-013-6882-5.
54. Villas-Boas SG, Smart KF, Sivakumaran S, Lane GA. Alkylation or silylation for analysis of amino and non-amino organic acids by GC-MSζ Metabolites (2011) 1(1):3-20. doi:10.3390/metabo1010003.
55. Ramautar R, de Jong GJ. Recent developments in liquid-phase separation techniques for metabolomics. Bioanalysis (2014) 6(7):1011-26. doi:10.4155/bio.14.51.
56. Kaiser T, Wittke S, Just I, Krebs R, Bartel S, Fliser D, et al. Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use. Electrophoresis (2004) 25(13):2044-55. doi:10.1002/elps.200305788.
57. Ramautar R, Busnel JM, Deelder AM, Mayboroda OA. Enhancing the coverage of the urinary metabolome by sheathless capillary electrophoresis-mass spectrometry. Anal Chem (2012) 84(2):885-92. doi:10.1021/ac202407v.
58. Hirayama A, Nakashima E, Sugimoto M, Akiyama S, Sato W, Maruyama S, et al. Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy. Anal Bioanal Chem (2012) 404(10):3101-9. doi:10.1007/s00216-012-6412-x.
59. Koulman A, Lane GA, Harrison SJ, Volmer DA. From differentiating metabolites to biomarkers. Anal Bioanal Chem (2009) 394(3):663-70. doi:10.1007/s00216-009-2690-3.
60. Storey JD. A direct approach to false discovery rates. J Roy Stat Soc B (2002) 64:479-98. doi:10.1111/1467-9868.00346.
61. Storey JD. The positive false discovery rate: a Bayesian interpretation and the q-value. Ann Stat (2003) 31(6):2013-35. doi:10.1214/aos/1074290335.
62. Gowda GA, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D. Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn (2008) 8(5):617-33. doi:10.1586/14737159.8.5.617.
63. Lindon JC, Nicholson JK. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu Rev Anal Chem (2008) 1:45-69. doi:10.1146/annurev.anchem.1.031207.113026.
64. Patel NR, McPhail MJ, Shariff MI, Keun HC, Taylor-Robinson SD. Biofluid metabonomics using (1)H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology. Expert Rev Gastroenterol Hepatol (2012) 6(2):239-51. doi:10.1586/egh.12.1.
65. Waters NJ. The role of metabonomics at the interface between drug metabolism and safety assessment. Curr Drug Metab (2010) 11(8):686-92. doi:10.2174/138920010794233512.
66. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res (2006) 34(Database issue):D354-7. doi:10.1093/nar/gkj102.
67. Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, de Bono B, et al. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res (2009) 37(Database issue):D619-22. doi:10.1093/nar/gkn863.
68. Caspi R, Altman T, Dreher K, Fulcher CA, Subhraveti P, Keseler IM, et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res (2012) 40(Database issue):D742-53. doi:10.1093/nar/gkr1014.
69. Paley SM, Karp PD. The pathway tools cellular overview diagram and omics viewer. Nucleic Acids Res (2006) 34(13):3771-8. doi:10.1093/nar/gkl334.
70. Garcia-Alcalde F, Garcia-Lopez F, Dopazo J, Conesa A. Paintomics: a web based tool for the joint visualization of transcriptomics and metabolomics data. Bioinformatics (2011) 27(1):137-9. doi:10.1093/bioinformatics/btq594.
71. Junker BH, Klukas C, Schreiber F. VANTED: a system for advanced data analysis and visualization in the context of biological networks. BMC Bioinformatics (2006) 7:109. doi:10.1186/1471-2105-7-109.
72. Klukas C, Schreiber F. Integration of-omics data and networks for biomedical research with VANTED. J Integr Bioinform (2010) 7(2):112. doi:10.2390/biecoll-jib-2010-112.
73. Karnovsky A, Weymouth T, Hull T, Tarcea VG, Scardoni G, Laudanna C, et al. Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics (2012) 28(3):373-80. doi:10.1093/bioinformatics/btr661.
74. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 13(11):2498-504. doi:10.1101/gr.1239303.
75. Gasse P, Riteau N, Charron S, Girre S, Fick L, Petrilli V, et al. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med (2009) 179(10):903-13. doi:10.1164/rccm.200808-1274OC.
76. Kono H, Chen CJ, Ontiveros F, Rock KL. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest (2010) 120(6):1939-49. doi:10.1172/JCI40124.
77. Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol (2012) 8(2):e1002375. doi:10.1371/journal.pcbi.1002375.
78. Chagoyen M, Pazos F. MBRole: enrichment analysis of metabolomic data. Bioinformatics (2011) 27(5):730-1. doi:10.1093/bioinformatics/btr001.
79. Kuo TC, Tian TF, Tseng YJ. 3Omics: a web-based systems biology tool for analysis, integration and visualization of human transcriptomic, proteomic and metabolomic data. BMC Syst Biol (2013) 7:64. doi:10.1186/1752-0509-7-64.
80. Xia J, Wishart DS. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res (2010) 38(Web Server issue):W71-7. doi:10.1093/nar/gkq329.
81. Barupal DK, Haldiya PK, Wohlgemuth G, Kind T, Kothari SL, Pinkerton KE, et al. MetaMapp: mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity. BMC Bioinformatics (2012) 13:99. doi:10.1186/1471-2105-13-99.
82. Grapov D, Wanichthanarak K, Fiehn O. MetaMapR: pathway independent metabolomic network analysis incorporating unknowns. Bioinformatics (2015) 31(16):2757-60. doi:10.1093/bioinformatics/btv194.
83. Sartor MA, Ade A, Wright Z, States D, Omenn GS, Athey B, et al. Metab2MeSH: annotating compounds with medical subject headings. Bioinformatics (2012) 28(10):1408-10. doi:10.1093/bioinformatics/bts156.
84. Mendes P, Camacho D, de la Fuente A. Modelling and simulation for metabolomics data analysis. Biochem Soc Trans (2005) 33(Pt 6):1427-9. doi:10.1042/BST20051427.
85. de la Fuente A, Bing N, Hoeschele I, Mendes P. Discovery of meaningful associations in genomic data using partial correlation coefficients. Bioinformatics (2004) 20(18):3565-74. doi:10.1093/bioinformatics/bth445.
86. Krumsiek J, Suhre K, Illig T, Adamski J, Theis FJ. Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data. BMC Syst Biol (2011) 5:21. doi:10.1186/1752-0509-5-21.
87. Krumsiek J, Suhre K, Evans AM, Mitchell MW, Mohney RP, Milburn MV, et al. Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information. PLoS Genet (2012) 8(10):e1003005. doi:10.1371/journal.pgen.1003005.
88. Ravanbakhsh S, Liu P, Bjorndahl TC, Mandal R, Grant JR, Wilson M, et al. Accurate, fully-automated NMR spectral profiling for metabolomics. PLoS One (2015) 10(5):e0124219. doi:10.1371/journal.pone.0124219.
89. Ridgway EJ, Tremlett CH, Allen KD. Capsular serotypes and antibiotic sensitivity of Streptococcus pneumoniae isolated from primary-school children. J Infect (1995) 30(3):245-51. doi:10.1016/S0163-4453(95)90831-5.
90. Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom SJ, Lipman HB, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med (1997) 157(15):1709-18. doi:10.1001/archinte.157.15.1709.
91. Wheelock CE, Goss VM, Balgoma D, Nicholas B, Brandsma J, Skipp PJ, et al. Application of 'omics' technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J (2013) 42(3):802-25. doi:10.1183/09031936.00078812.
92. Slupsky CM, Rankin KN, Fu H, Chang D, Rowe BH, Charles PG, et al. Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. J Proteome Res (2009) 8(12):5550-8. doi:10.1021/pr9006427.
93. Laiakis EC, Morris GA, Fornace AJ, Howie SR. Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study. PLoS One (2010) 5(9):e12655. doi:10.1371/journal.pone.0012655.
94. Asrar Khan W, Woodhead M. Major advances in managing community-acquired pneumonia. F1000Prime Rep (2013) 5:43. doi:10.12703/P5-43.
95. Gattinoni L, Cressoni M, Brazzi L. Fluids in ARDS: from onset through recovery. Curr Opin Crit Care (2014) 20(4):373-7. doi:10.1097/MCC.0000000000000105.
96. Martin TR, Matute-Bello G. Experimental models and emerging hypotheses for acute lung injury. Crit Care Clin (2011) 27(3):735-52. doi:10.1016/j.ccc.2011.05.013.
97. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med (2000) 342(18):1334-49. doi:10.1056/NEJM200005043421806.
98. Li G, Malinchoc M, Cartin-Ceba R, Venkata CV, Kor DJ, Peters SG, et al. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med (2011) 183(1):59-66. doi:10.1164/rccm.201003-0436OC.
99. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med (2005) 353(16):1685-93. doi:10.1056/NEJMoa050333.
100. Vadasz I, Brochard L. Update in acute lung injury and mechanical ventilation 2011. Am J Respir Crit Care Med (2012) 186(1):17-23. doi:10.1164/rccm.201203-0582UP.
101. Beloncle F, Lorente JA, Esteban A, Brochard L. Update in acute lung injury and mechanical ventilation 2013. Am J Respir Crit Care Med (2014) 189(10):1187-93. doi:10.1164/rccm.201402-0262UP.
102. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA (2012) 307(23):2526-33. doi:10.1001/jama.2012.5669.
103. Villar J, Blanco J, Del Campo R, Andaluz-Ojeda D, Diaz-Dominguez FJ, Muriel A, et al. Assessment of PaO2/FiO2 for stratification of patients with moderate and severe acute respiratory distress syndrome. BMJ Open (2015) 5(3):e006812. doi:10.1136/bmjopen-2014-006812.
104. MacLaren R, Stringer KA. Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome. Pharmacotherapy (2007) 27(6):860-73. doi:10.1592/phco.27.6.860.
105. Calfee CS, Janz DR, Bernard GR, May AK, Kangelaris KN, Matthay MA, et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest (2015) 147(6):1539-48. doi:10.1378/chest.14-2454.
106. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol (2011) 44(5):725-38. doi:10.1165/rcmb.2009-0210ST.
107. Matute-Bello G, Downey GP. Reply: defining lung injury in animals. Am J Respir Cell Mol Biol (2013) 48(2):267-8. doi:10.1165/rcmb.2011-0198LE.
108. Izquierdo-Garcia JL, Naz S, Nin N, Rojas Y, Erazo M, Martinez-Caro L, et al. A metabolomic approach to the pathogenesis of ventilator-induced lung injury. Anesthesiology (2014) 120(3):694-702. doi:10.1097/ALN.0000000000000074.
109. Dos Santos CC, Slutsky AS. Invited review: mechanisms of ventilator-induced lung injury: a perspective. J Appl Physiol (1985) (2000) 89(4):1645-55.
110. Bos LD, van Walree IC, Kolk AH, Janssen HG, Sterk PJ, Schultz MJ. Alterations in exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury. J Appl Physiol (1985) (2013) 115(10):1487-95. doi:10.1152/japplphysiol.00685.2013.
111. Bos LD, Weda H, Wang Y, Knobel HH, Nijsen TM, Vink TJ, et al. Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome. Eur Respir J (2014) 44(1):188-97. doi:10.1183/09031936.00005614.
112. Murakami K, Enkhbaatar P, Yu YM, Traber LD, Cox RA, Hawkins HK, et al. L-arginine attenuates acute lung injury after smoke inhalation and burn injury in sheep. Shock (2007) 28(4):477-83. doi:10.1097/shk.0b013e31804a59bd.
113. Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M, et al. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circ Res (2003) 92(2):226-33. doi:10.1161/01.RES.0000052990.68216.EF.
114. Cantoni GL. Biological methylation: selected aspects. Annu Rev Biochem (1975) 44:435-51. doi:10.1146/annurev.bi.44.070175.002251.
115. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A (1998) 95(16):9220-5. doi:10.1073/pnas.95.16.9220.
116. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A (1996) 93(13):6770-4. doi:10.1073/pnas.93.13.6770.
117. Serkova NJ, Van Rheen Z, Tobias M, Pitzer JE, Wilkinson JE, Stringer KA. Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol (2008) 295(1):L152-61. doi:10.1152/ajplung.00515.2007.
118. Parker JC, Townsley MI. Evaluation of lung injury in rats and mice. Am J Physiol Lung Cell Mol Physiol (2004) 286(2):L231-46. doi:10.1152/ajplung.00049.2003.
119. Schubert JK, Muller WP, Benzing A, Geiger K. Application of a new method for analysis of exhaled gas in critically ill patients. Intensive Care Med (1998) 24(5):415-21. doi:10.1007/s001340050589.
120. King J, Koc H, Unterkofler K, Mochalski P, Kupferthaler A, Teschl G, et al. Physiological modeling of isoprene dynamics in exhaled breath. J Theor Biol (2010) 267(4):626-37. doi:10.1016/j.jtbi.2010.09.028.
121. Chiarla C, Giovannini I, Giuliante F, Zadak Z, Vellone M, Ardito F, et al. Severe hypocholesterolemia in surgical patients, sepsis, and critical illness. J Crit Care (2010) 25(2):e7-12. doi:10.1016/j.jcrc.2009.08.006.
122. Cross CE, Forte T, Stocker R, Louie S, Yamamoto Y, Ames BN, et al. Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J Lab Clin Med (1990) 115(4):396-404.
123. Gajic O, Dabbagh O, Park PK, Adesanya A, Chang SY, Hou P, et al. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med (2011) 183(4):462-70. doi:10.1164/rccm.201004-0549OC.
124. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med (1985) 13(10):818-29. doi:10.1097/00003246-198510000-00009.
125. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA (1993) 270(24):2957-63. doi:10.1001/jama.1993.03510240069035.
126. Hornuss C, Zagler A, Dolch ME, Wiepcke D, Praun S, Boulesteix AL, et al. Breath isoprene concentrations in persons undergoing general anesthesia and in healthy volunteers. J Breath Res (2012) 6(4):046004. doi:10.1088/1752-7155/6/4/046004.
127. Riely CA, Cohen G, Lieberman M. Ethane evolution: a new index of lipid peroxidation. Science (1974) 183(4121):208-10. doi:10.1126/science.183.4121.208.
128. Horvat RJ, Lane WG, Ng H, Shepherd AD. Saturated hydrocarbons from autoxidizing methyl linoleate. Nature (1964) 203:523-4. doi:10.1038/203523b0.
129. Bos LD, Sterk PJ, Schultz MJ. Volatile metabolites of pathogens: a systematic review. PLoS Pathog (2013) 9(5):e1003311. doi:10.1371/journal.ppat.1003311.
130. Shin HW, Umber BJ, Meinardi S, Leu SY, Zaldivar F, Blake DR, et al. Acetaldehyde and hexanaldehyde from cultured white cells. J Transl Med (2009) 7:31. doi:10.1186/1479-5876-7-31.
131. Kneepkens CM, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med (1994) 17(2):127-60. doi:10.1016/0891-5849(94)90110-4.
132. Agassandian M, Mallampalli RK. Surfactant phospholipid metabolism. Biochim Biophys Acta (2013) 1831(3):612-25. doi:10.1016/j.bbalip.2012.09.010.
133. World Health Organization. Air Pollution Estimates. Geneva: WHO (2014). [cited 2015 Apr 9]. Available from: http://www.who.int/phe/health_topics/outdoorair/databases/FINAL_HAP_AAP_BoD_24March2014.pdf?ua=1.
134. International Agency for Research on Cancer. IARC: Outdoor Air Pollution a Leading Environmental Cause of Cancer Deaths. (2013). [cited 2015 April 9]. Available from: http://www.iarc.fr/en/media-centre/iarcnews/pdf/pr221_E.pdf.
135. National Institute for Occupational Safety and Health. Atlas of Respiratory Disease Mortality, United States: 1982-1993. Cincinnati: Center for Disease Control and Prevention, NIOSH (1998).
136. Delfino RJ, Staimer N, Tjoa T, Arhami M, Polidori A, Gillen DL, et al. Association of biomarkers of systemic inflammation with organic components and source tracers in quasi-ultrafine particles. Environ Health Persp (2010) 118(6):756-62. doi:10.1289/ehp.0901407.
137. Blanc PD, Boushey HA, Wong H, Wintermeyer SF, Bernstein MS. Cytokines in metal fume fever. Am Rev Respir Dis (1993) 147(1):134-8. doi:10.1164/ajrccm/147.1.134.
138. Hoffmeyer F, Raulf-Heimsoth M, Weiss T, Lehnert M, Gawrych K, Kendzia B, et al. Relation between biomarkers in exhaled breath condensate and internal exposure to metals from gas metal arc welding. J Breath Res (2012) 6(2):1-8. doi:10.1088/1752-7155/6/2/027105.
139. Nuernberg AM, Boyce PD, Cavallari JM, Fang SC, Eisen EA, Christiani DC. Urinary 8-isoprostane and 8-OHdG concentrations in boilermakers with welding exposure. J Occup Environmental Med (2008) 50(2):182-9. doi:10.1097/JOM.0b013e31815cf6cc.
140. Brand P, Bischof K, Siry L, Bertram J, Schettgen T, Reisgen U, et al. Exposure of healthy subjects with emissions from a gas metal arc welding process: part 3-biological effect markers and lung function. Int Arch Occup Environ Health (2013) 86(1):39-45. doi:10.1007/s00420-012-0739-7.
141. Ellis JK, Athersuch TJ, Thomas LD, Teichert F, Perez-Trujillo M, Svendsen C, et al. Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human population. BMC Med (2012) 10:61. doi:10.1186/1741-7015-10-61.
142. Gao Y, Lu Y, Huang S, Gao L, Liang X, Wu Y, et al. Identifying early urinary metabolic changes with long-term environmental exposure to cadmium by mass-spectrometry-based metabolomics. Environ Sci Technol (2014) 48(11):6409-18. doi:10.1021/es500750w.
143. Suvagandha D, Nishijo M, Swaddiwudhipong W, Honda R, Ohse M, Kuhara T, et al. A biomarker found in cadmium exposed residents of Thailand by metabolome analysis. Int J Environ Res Public Health (2014) 11(4):3661-77. doi:10.3390/ijerph110403661.
144. Xi S, Zheng Q, Zhang Q, Sun G. Metabolic profile and assessment of occupational arsenic exposure in copper-and steel-smelting workers in China. Int Arch Occup Environ Health (2011) 84(3):347-53. doi:10.1007/s00420-010-0574-7.
145. Shen H, Zhang J, Xu W. Chemical and male infertility oriented metabolomics in population based health risk research: The case of arsenic. One Century of the Discovery of Arsenicosis in Latin America (1914-2014): As 2014-Proceedings of the 5th International Congress on Arsenic in the Environment. Buenos Aires, Argentina: CRC Press (2014). p. 646-7.
146. Dudka I, Kossowska B, Senhadri H, Latajka R, Hajek J, Andrzejak R, et al. Metabonomic analysis of serum of workers occupationally exposed to arsenic, cadmium and lead for biomarker research: a preliminary study. Environ Int (2014) 68:71-81. doi:10.1016/j.envint.2014.03.015.
147. Jeanneret F, Boccard J, Badoud F, Sorg O, Tonoli D, Pelclova D, et al. Human urinary biomarkers of dioxin exposure: analysis by metabolomics and biologically driven data dimensionality reduction. Toxicol Lett (2014) 230(2):234-43. doi:10.1016/j.toxlet.2013.10.031.
148. Boccard J, Jeanneret F, Sorg O, Saurat JH, Vlckova S, Pelclova D, et al. Discovery of biomarkers of dioxin intoxication in human urine: analysis by metabolomics and biologically-driven strategy. Toxicol Lett (2013) 221:S64. doi:10.1016/j.toxlet.2013.05.033.
149. Saberi Hosnijeh F, Pechlivanis A, Keun HC, Portengen L, Bueno-de-Mesquita HB, Heederik D, et al. Serum metabolomic pertubations among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Environ Mol Muta (2013) 54(7):558-65. doi:10.1002/em.21802.
150. Cave MC, Beier JI, Wheeler B, Falkner KC, Bellis-Jones HJ, Clair HB, et al. Occupational vinyl chloride exposures are associated with significant changes to the plasma metabolome: Implications for toxicant associated steatohepatitis. 63rd Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2012. Boston, MA: John Wiley and Sons Inc (2012). p. 882A-3A.
151. Kirpich I, Liu H, Falkner KC, Beier JI, Joshi-Barve S, Ramsden C, et al. Occupational vinyl chloride exposures increase plasma lipid peroxidation products (Including 13-hode) capable of causing mitochondiral dysfunction and endoplasmic reticulum stress-novel modes of action for toxicant associated steatohepatitis (TASH). 64th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2013. Washington, DC: John Wiley and Sons Inc (2013). 952A p.
152. Bonvallot N, Tremblay-Franco M, Chevrier C, Canlet C, Warembourg C, Cravedi JP, et al. Metabolomics tools for describing complex pesticide exposure in pregnant women in Brittany (France). PLoS One (2013) 8(5):e64433. doi:10.1371/journal.pone.0064433.
153. Senn T, Vredevoogd M, Vigoren E, Faustman E, Lin YS. Exposure assessment of pesticides and xenobiotics in spot urine collections. 10th International ISSX Meeting. Toronto, ON: Drug Metabolism Reviews (2014). p. 146-7.
154. Baccarelli A, Kaufman JD. Ambient particulate air pollution, environmental tobacco smoking, and childhood asthma: interactions and biological mechanisms. Am J Respir Crit Care Med (2011) 184(12):1325-7. doi:10.1164/rccm.201109-1695ED.
155. Butsch Kovacic M, Stigler S, Sauter S, Wu T, Ryan PH, Martin L, et al. Racial differences in traffic and environmental tobacco smoke exposure-induced systemic oxidative stress in children. American Thoracic Society Conference. Denver, CO: ATS Journals (2011).
156. Wang-Sattler R, Yu Y, Mittelstrass K, Lattka E, Altmaier E, Gieger C, et al. Metabolic profiling reveals distinct variations linked to nicotine consumption in humans-first results from the KORA study. PLoS One (2008) 3(12):e3863. doi:10.1371/journal.pone.0003863.
157. Xu T, Holzapfel C, Dong X, Bader E, Yu Z, Prehn C, et al. Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med (2013) 11:60. doi:10.1186/1741-7015-11-60.
158. Kuo CH, Wang KC, Tian TF, Tsai MH, Chiung YM, Hsiech CM, et al. Metabolomic characterization of laborers exposed to welding fumes. Chem Res Toxicol (2012) 25(3):676-86. doi:10.1021/tx200465e.
159. Wei Y, Wang Z, Chang CY, Fan T, Su L, Chen F, et al. Global metabolomic profiling reveals an association of metal fume exposure and plasma unsaturated fatty acids. PLoS One (2013) 8(10):e77413. doi:10.1371/journal.pone.0077413.
160. Mannino D, Holguin F, Greves H, Savage-Brown A, Stock A, Jones R. Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey. Thorax (2004) 59(3):194-8. doi:10.1136/thorax.2003.012054.
161. International Agency for Research on Cancer. Beryllium, Cadmium, Mercury, and Exposures in the Glass Manufacturing Industry. Geneva: IARC (1993).
162. Bakakos P, Kostikas K, Loukides S. Smoking asthma phenotype: diagnostic and management challenges. Curr Opin Pulm Med (2016) 22(1):53-8. doi:10.1097/MCP.0000000000000221.
163. Beach JR, Dennis JH, Avery AJ, Bromly CL, Ward RJ, Walters EH, et al. An epidemiologic investigation of asthma in welders. Am J Resp Crit Care Med (1996) 154(5):1394-400. doi:10.1164/ajrccm.154.5.8912754.
164. Coggon D, Inskip H, Winter P, Pannett B. Lobar pneumonia: an occupational disease in welders. Lancet (1994) 344(8914):41-3. doi:10.1016/S0140-6736(94)91056-1.